CBC With Differential/Platelet
WBC 5.1 x10E3/uL 3.4 - 10.8 01
RBC 5.02 x10E6/uL 4.14 - 5.80 01
Hemoglobin 15.0 g/dL 12.6 - 17.7 01
Hematocrit 45.1 % 37.5 - 51.0 01
MCV 90 fL 79 - 97 01
MCH 29.9 pg 26.6 - 33.0 01
MCHC 33.3 g/dL 31.5 - 35.7 01
RDW 14.5 % 12.3 - 15.4 01
Platelets 245 x10E3/uL 150 - 379 01
Neutrophils 58 % 01
Lymphs 34 % 01
Monocytes 6 % 01
Eos 2 % 01
Basos 0 % 01
Neutrophils (Absolute) 2.9 x10E3/uL 1.4 - 7.0 01
Lymphs (Absolute) 1.7 x10E3/uL 0.7 - 3.1 01
Monocytes(Absolute) 0.3 x10E3/uL 0.1 - 0.9 01
Eos (Absolute) 0.1 x10E3/uL 0.0 - 0.4 01
Baso (Absolute) 0.0 x10E3/uL 0.0 - 0.2 01
Immature Granulocytes 0 % 01
Immature Grans (Abs) 0.0 x10E3/uL 0.0 - 0.1 01
Comp. Metabolic Panel (14)
Glucose, Serum 100 High mg/dL 65 - 99 01
BUN 17 mg/dL 6 - 24 01
Creatinine, Serum 0.84 mg/dL 0.76 - 1.27 01
eGFR If NonAfricn Am 110 mL/min/1.73 >59
eGFR If Africn Am 127 mL/min/1.73 >59
BUN/Creatinine Ratio 20 9 - 20
Sodium, Serum 141 mmol/L 134 - 144 01
Potassium, Serum 4.2 mmol/L 3.5 - 5.2 01
Chloride, Serum 102 mmol/L 97 - 108 01
Carbon Dioxide, Total 25 mmol/L 18 - 29 01
Calcium, Serum 9.6 mg/dL 8.7 - 10.2 01
Protein, Total, Serum 7.1 g/dL 6.0 - 8.5 01
Albumin, Serum 4.7 g/dL 3.5 - 5.5 01
Globulin, Total 2.4 g/dL 1.5 - 4.5
A/G Ratio 2.0 1.1 - 2.5
Bilirubin, Total 0.5 mg/dL 0.0 - 1.2 01
Alkaline Phosphatase, S 80 IU/L 39 - 117 01
AST (SGOT) 19 IU/L 0 - 40 01
ALT (SGPT) 24 IU/L 0 - 44 01
Urinalysis, Complete
Urinalysis Gross Exam 01
Specific Gravity
No urine specimen received. 1.005 - 1.030 01
Lipid Panel With LDL/HDL Ratio
Cholesterol, Total 162 mg/dL 100 - 199 01
Triglycerides 67 mg/dL 0 - 149 01
HDL Cholesterol 50 mg/dL >39 01
Comment 01
According to ATP-III Guidelines, HDL-C >59 mg/dL is considered a
negative risk factor for CHD.
VLDL Cholesterol Cal 13 mg/dL 5 - 40
LDL Cholesterol Calc 99 mg/dL 0 - 99
LDL/HDL Ratio 2.0 ratio units 0.0 - 3.6
Please Note: 01
LDL/HDL Ratio
Men Women
1/2 Avg.Risk 1.0 1.5
Avg.Risk 3.6 3.2
2X Avg.Risk 6.2 5.0
3X Avg.Risk 8.0 6.1
Testosterone,Free and Total
Testosterone, Serum 419 ng/dL 348 - 1197 01
Comment:
Adult male reference interval is based on a population of lean males
up to 40 years old.
Free Testosterone(Direct) 8.8 pg/mL 6.8 - 21.5 02
ABO Grouping A 01
Rh Factor Positive 01
Please note: Prior records for this patient's ABO / Rh type are not
available for additional verification.
FSH and LH
LH 4.7 mIU/mL 1.7 - 8.6 01
FSH 3.0 mIU/mL 1.5 - 12.4 01
Hemoglobin A1c
Hemoglobin A1c 5.4 % 4.8 - 5.6 01
Please Note: 01
Pre-diabetes: 5.7 - 6.4
Diabetes: >6.4
Glycemic control for adults with diabetes: <7.0
Thyroxine (T4) Free, Direct, S
T4,Free(Direct) 1.39 ng/dL 0.82 - 1.77 01
CEA 1.2 ng/mL 0.0 - 4.7 01
Roche ECLIA methodology Nonsmokers <3.9
Smokers <5.6
AFP, Serum, Tumor Marker 1.7 ng/mL 0.0 - 8.3 01
Roche ECLIA methodology
TSH 2.690 uIU/mL 0.450 - 4.500 01
Estradiol 29.5 pg/mL 7.6 - 42.6 01
Roche ECLIA methodology
Prostate-Specific Ag, Serum
Prostate Specific Ag, Serum 0.5 ng/mL 0.0 - 4.0 01
Roche ECLIA methodology.
According to the American Urological Association, Serum PSA should
decrease and remain at undetectable levels after radical
prostatectomy. The AUA defines biochemical recurrence as an initial
PSA value 0.2 ng/mL or greater followed by a subsequent confirmatory
PSA value 0.2 ng/mL or greater.
Values obtained with different assay methods or kits cannot be used
interchangeably. Results cannot be interpreted as absolute evidence
of the presence or absence of malignant disease.
IGF-1
Insulin-Like Growth Factor I 187 ng/mL 83 - 233 02
Vitamin D, 25-Hydroxy 50.6 ng/mL 30.0 - 100.0 01
Vitamin D deficiency has been defined by the Institute of
Medicine and an Endocrine Society practice guideline as a
level of serum 25-OH vitamin D less than 20 ng/mL (1,2).
The Endocrine Society went on to further define vitamin D
insufficiency as a level between 21 and 29 ng/mL (2).
1. IOM (Institute of Medicine). 2010. Dietary reference
intakes for calcium and D. Washington DC: The
National Academies Press.
2. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al.
Evaluation, treatment, and prevention of vitamin D
deficiency: an Endocrine Society clinical practice
guideline. JCEM. 2011 Jul; 96(7):1911-30.
Triiodothyronine (T3) 100 ng/dL 71 - 180 01
Sorry for posting anything not relevant please disregard.
Appreciate any comments or advice, thanks in advance.
